Your browser doesn't support javascript.
loading
EPAS1 Promoter Hypermethylation is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer.
Zhang, Mingfang; Li, Jing; Lin, Weibin; Qi, Lin; Yao, Caiyun; Zheng, Zhonghua; Chen, Chujia; Duan, Shiwei; Qi, Yuanlin.
Affiliation
  • Zhang M; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Li J; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Lin W; Department of Pathology, Fujian Provincial Maternity Hospital, Fuzhou, China.
  • Qi L; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Yao C; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Zheng Z; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Chen C; Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China.
  • Duan S; Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China.
  • Qi Y; Department of Clinical Medicine, School of Medicine, Zhejiang University City College, Hangzhou, China.
Genet Test Mol Biomarkers ; 26(7-8): 360-374, 2022.
Article in En | MEDLINE | ID: mdl-35920832
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article